Publicaciones en las que colabora con José Antonio Castillo Sánchez (8)

2006

  1. Neurorepair versus neuroprotection in stroke

    Cerebrovascular Diseases, Vol. 21, Núm. SUPPL. 2, pp. 54-63

  2. Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J 2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms

    Journal of Cerebral Blood Flow and Metabolism, Vol. 26, Núm. 2, pp. 218-229

  3. Targets of cytoprotection in acute ischemic stroke: Present and future

    Cerebrovascular Diseases, Vol. 21, Núm. SUPPL. 2, pp. 1-8

2005

  1. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia

    Neurobiology of Disease, Vol. 18, Núm. 2, pp. 375-384

  2. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: Effects on glutamate transport

    Neurobiology of Disease, Vol. 18, Núm. 2, pp. 336-345

  3. TNFR1 upregulation mediates tolerance after brain ischemic preconditioning

    Journal of Cerebral Blood Flow and Metabolism, Vol. 25, Núm. 2, pp. 193-203

2002

  1. Upregulation of TACE/ADAM17 after ischemic preconditioning is involved in brain tolerance

    Journal of Cerebral Blood Flow and Metabolism, Vol. 22, Núm. 11, pp. 1297-1302

2001

  1. Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats

    Journal of Neurochemistry, Vol. 79, Núm. 2, pp. 456-459